Oxford stops study of COVID AstraZeneca vaccine in children and adolescents on blood clotting problem
Oxford stops study of COVID AstraZeneca vaccine in children and adolescents on blood clotting problem
The single dose of AstraZeneca or Pfizer COVID-19 vaccine reduces the risk of hospitalization by more than 80%, the study shows
The UK becomes the first country to launch the AstraZeneca-Oxford vaccine, as imminent blockades will be tightened